Advanced Medical Solutions Group (LON:AMS) Stock Price Down 25.4% – Here’s Why

Advanced Medical Solutions Group plc (LON:AMS)’s stock price was down 25.4% on Monday . The company traded as low as GBX 187 and last traded at GBX 191.27. Approximately 48,315,629 shares changed hands during trading, an increase of 2,269% from the average daily volume of 2,039,652 shares. The stock had previously closed at GBX 256.26.

Analyst Ratings Changes

A number of analysts have weighed in on AMS shares. Royal Bank Of Canada reissued a “sector perform” rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Berenberg Bank reissued a “buy” rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Tuesday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The firm has a market cap of £453.11 million, a price-to-earnings ratio of 46.21, a P/E/G ratio of 5.00 and a beta of 0.72. The business’s 50-day simple moving average is GBX 218.80 and its two-hundred day simple moving average is GBX 216.31. The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. As a group, research analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.